| Literature DB >> 30779948 |
Douglas L Feinstein1, Kamil Gierzal2, Asif Iqbal3, Sergey Kalinin4, Richard Ripper5, Matthew Lindeblad6, Alexander Zahkarov7, Alexander Lyubimov8, Richard van Breemen9, Guy Weinberg10, Israel Rubinstein11.
Abstract
Brodifacoum (BDF) is a potent, long-acting anticoagulant rodenticide that can cause fatal poisoning in humans. The chemical structure of BDF includes 2 chiral carbons, resulting in 2 pairs of diastereomers, BDF-cis (R/S and S/R) and BDF-trans (R/R and S/S). However, the relative potency of these molecules is not known. The purpose of this study was to compare the in vitro and in vivo toxic effects of the 2 BDF diastereomer pairs. In adult Sprague-Dawley rats BDF-cis was significantly more toxic than BDF-trans (LD50 values of 219 versus 316 μg/kg, respectively) while racemic BDF had intermediate potency (266 μg/kg). In adult New Zealand white rabbits, BDF-cis had a longer half-life than BDF-trans which could contribute to its observed increased toxicity. Lastly, BDF-cis (10 μM), but not BDF-trans, damaged cultured SH-SY5Y human neuroblastoma cells by attenuating mitochondrial reductive capacity. Taken together, these data suggest that different toxic manifestations of BDF poisoning in mammals could be attributed, in part, to differences in relative enantiomer concentrations present in racemic formulations of this commercially-available toxicant. Published by Elsevier B.V.Entities:
Keywords: Anticoagulation; Brodifacoum; Diastereomer; Enantiomer; Superwarfarins
Mesh:
Substances:
Year: 2019 PMID: 30779948 PMCID: PMC6408973 DOI: 10.1016/j.toxlet.2019.02.011
Source DB: PubMed Journal: Toxicol Lett ISSN: 0378-4274 Impact factor: 4.372